Simons Searchlight
Recent articles
Simons Foundation clinical research head Wendy Chung to lead Boston Children’s pediatrics department
Chung, a clinical and molecular geneticist, plans to continue serving as principal investigator of two large research projects involving cohorts of people with autism and related neurodevelopmental conditions.
Simons Foundation clinical research head Wendy Chung to lead Boston Children’s pediatrics department
Chung, a clinical and molecular geneticist, plans to continue serving as principal investigator of two large research projects involving cohorts of people with autism and related neurodevelopmental conditions.
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.